🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12361+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12361 recruiting trials

Phase 1RecruitingNCT06049082

A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

👨‍⚕️ David Sweet, MD, PhD, Director of Clinical Development📍 3 sites📅 Started Feb 2024View details ↗
NARecruitingNCT06838637

Transcutaneous Spinal Cord Stimulation Home Study

👨‍⚕️ Michael J Berger, MD, FRCPC, The University of British Columbia📍 1 site📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT06298409

Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®

👨‍⚕️ George Triadafilopoulos, Silicon Valley Gastroenterology📍 1 site📅 Started Feb 2024View details ↗
Phase 3RecruitingNCT06230224

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 99 sites📅 Started Feb 2024View details ↗
Phase 1, PHASE2RecruitingNCT05145816

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

👨‍⚕️ Larry Anderson, MD, University of Texas Southwestern Medical Center📍 3 sites📅 Started Feb 2024View details ↗
NARecruitingNCT06398496

The Effects of Exercise on Gut Bacteria, Mood and Cognition in Depression

👨‍⚕️ Gerard Clarke, PhD, University College Cork, APC Microbiome Ireland📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05149768

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

👨‍⚕️ Janet E Pope, PhD, University of Western Ontario, Division of Rheumatology, St. Joseph's Health Care, London, Ontario, Canada📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05635344

A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

👨‍⚕️ Ehsan Ghorani, Imperial College London University📍 1 site📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT05979389

Bicalutamide Therapy in Young Women With NAFLD and PCOS

👨‍⚕️ Monika A Sarkar, MD, MAS, University of California, San Francisco📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06774326

Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines

👨‍⚕️ Vincenzo Russo, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05969275

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

👨‍⚕️ Lauralyn McIntyre, MD, Ottawa Hospital Research Institute📍 2 sites📅 Started Feb 2024View details ↗
Phase 4RecruitingNCT05837091

Low Sodium Oxybate in Patients With Idiopathic Hypersomnia

👨‍⚕️ Chad Ruoff, MD, Mayo Clinic📍 4 sites📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT04881240

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

👨‍⚕️ Aimee C. Talleur, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06298448

eGPA and Local Inflammation Within the Ear, Nose and Throat Area

🏥 University Medical Center Groningen📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT04941599

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

👨‍⚕️ MacRae F. Linton, MD, Vanderbilt University Medical Center📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05998642

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma

👨‍⚕️ Jean-Francois Larouche, CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Quebec City, QC Canada📍 8 sites📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT06313203

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

🏥 Oslo University Hospital📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05386394

Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia

👨‍⚕️ Kyrana Tsapkini, PhD., Johns Hopkins University📍 3 sites📅 Started Feb 2024View details ↗
RecruitingNCT06078553

A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

🏥 argenx📍 19 sites📅 Started Feb 2024View details ↗
Phase 1, PHASE2RecruitingNCT06199531

Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency

🏥 Grace Science, LLC📍 3 sites📅 Started Feb 2024View details ↗
← PreviousPage 327 of 619Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →